NEOGENOMICS INC (NEO)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 300M 600M 900M Q2 '24: 628.2M Q3 '24: 644.1M Q4 '24: 660.6M Q1 '25: 672.4M Q2 '25: 689.2M Q3 '25: 709.2M Q4 '25: 727.3M Q1 '26: 746M Q2 '24 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26

Gross Profit TTM

0 150M 300M 450M Q2 '24: 267.9M Q3 '24: 280.4M Q4 '24: 290.1M Q1 '25: 297.9M Q2 '25: 302.6M Q3 '25: 308.2M Q4 '25: 314.3M Q1 '26: 321.9M Q2 '24 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26

Operating Income TTM

-150M -100M -50M 0 50M 100M 150M Q2 '24: -95.3M Q3 '24: -92.3M Q4 '24: -92.1M Q1 '25: -89.4M Q2 '25: -115.1M Q3 '25: -120.9M Q4 '25: -115.9M Q1 '26: -106.3M Q2 '24 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26

Net Income TTM

-120M -80M -40M 0 40M 80M 120M Q2 '24: -78.5M Q3 '24: -77.7M Q4 '24: -78.7M Q1 '25: -77.6M Q2 '25: -104M Q3 '25: -113.5M Q4 '25: -108M Q1 '26: -99.2M Q2 '24 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26

Cost of Revenue TTM

0 150M 300M 450M Q2 '24: 360.4M Q3 '24: 363.7M Q4 '24: 370.5M Q1 '25: 374.5M Q2 '25: 386.5M Q3 '25: 401M Q4 '25: 413M Q1 '26: 424.1M Q2 '24 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26

Operating Cash Flow TTM

0 8M 16M 24M Q2 '24: 264K Q3 '24: 15M Q4 '24: 7M Q1 '25: 7.6M Q2 '25: 14M Q3 '25: 13.7M Q4 '25: 5.2M Q1 '26: 22.4M Q2 '24 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26

Free Cash Flow TTM

-45M -30M -15M 0 15M 30M 45M Q2 '24: -29.7M Q3 '24: -21.5M Q4 '24: -34M Q1 '25: -32.4M Q2 '25: -19.2M Q3 '25: -17M Q4 '25: -21.8M Q1 '26: -5.1M Q2 '24 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 50M 100M 150M Q3 '23: 125.7M Q1 '24: 126.1M Q2 '24: 126.4M Q3 '24: 127M Q1 '25: 127.4M Q2 '25: 127.9M Q3 '25: 128.4M Q1 '26: 129.2M Q3 '23 Q1 '24 Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.06 -0.04 -0.02 0.00 0.02 0.04 0.06 Q1 '14: 0.05 Q2 '14: 0.05 Q3 '14: 0.02 Q4 '14: 0.02 Q1 '15: 0.01 Q2 '15: 0.00 Q3 '15: 0.01 Q4 '15: -0.04 Q1 '14 Q2 '14 Q3 '14 Q4 '14 Q1 '15 Q2 '15 Q3 '15 Q4 '15

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.